264 results
Page 8 of 14
SC TO-C
7c0i1mfy2 6cdvijg
21 Apr 11
Information about tender offer
12:00am
PRRN14A
javsi2
18 Apr 11
Revised preliminary proxy statement filed by non-management
12:00am
8-K/A
z4wyz
14 Mar 11
Changes in Registrant's Certifying Accountant
12:00am
8-K
EX-4.1
vx3l5x
10 Mar 11
Entry into a Material Definitive Agreement
12:00am
8-K/A
v1zb4xqjamvgxelw
2 Mar 11
Changes in Registrant's Certifying Accountant
12:00am
8-K
EX-4.1
5do6nkipjdzw avtxo
9 Feb 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.2
88aj7jsv
27 Dec 10
Valeant Pharmaceuticals Appoints Philip W. Loberg As Interim Cfo
12:00am
8-K
EX-4.1
lxmczgy8
26 Nov 10
Entry into a Material Definitive Agreement
12:00am
8-K
tt6yfxe vs9dzs72nj
26 Nov 10
Changes in Registrant's Certifying Accountant
12:00am
S-3D
ybh v0k0m
9 Nov 10
Registration of securities, dividend or interest reinvestment plans, immediately effective
12:00am
S-3D
EX-4.6
8f4p2 8r3e
9 Nov 10
Registration of securities, dividend or interest reinvestment plans, immediately effective
12:00am
8-K
EX-99.1
43qcuwij1gnxzb13
1 Oct 10
Valeant and Biovail Announce Results of Special Meetings of Shareholders
12:00am
8-K
EX-4.3
pmzzu
1 Oct 10
Valeant and Biovail Announce Results of Special Meetings of Shareholders
12:00am
8-K
EX-10.1
d9tvrcf9es9 kb6tk
1 Oct 10
Valeant and Biovail Announce Results of Special Meetings of Shareholders
12:00am
8-K
EX-4.1
ud4an0y1yqrzar4 qmt
1 Oct 10
Valeant and Biovail Announce Results of Special Meetings of Shareholders
12:00am
8-K
4cyq c9ri
1 Oct 10
Valeant and Biovail Announce Results of Special Meetings of Shareholders
12:00am
S-8 POS
EX-4.1
g8uuuppzeohi3
28 Sep 10
Registration of securities for employees (post-effective amendment)
12:00am
425
6opwxgl yyje4q4
27 Sep 10
Business combination disclosure
12:00am
425
2vrb4828bvgr
22 Sep 10
Business combination disclosure
12:00am